BR112023005002A2 - Geração de linhagem de células de ovário de hamster chinês recombinantes de alta produção para produção de proteína terapêutica - Google Patents
Geração de linhagem de células de ovário de hamster chinês recombinantes de alta produção para produção de proteína terapêuticaInfo
- Publication number
- BR112023005002A2 BR112023005002A2 BR112023005002A BR112023005002A BR112023005002A2 BR 112023005002 A2 BR112023005002 A2 BR 112023005002A2 BR 112023005002 A BR112023005002 A BR 112023005002A BR 112023005002 A BR112023005002 A BR 112023005002A BR 112023005002 A2 BR112023005002 A2 BR 112023005002A2
- Authority
- BR
- Brazil
- Prior art keywords
- yearing
- chinese hamster
- hamster ovary
- therapeutic protein
- ovary cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
- C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
- C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20306068 | 2020-09-21 | ||
| PCT/EP2021/075864 WO2022058603A1 (en) | 2020-09-21 | 2021-09-21 | Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023005002A2 true BR112023005002A2 (pt) | 2023-04-18 |
Family
ID=72840426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023005002A BR112023005002A2 (pt) | 2020-09-21 | 2021-09-21 | Geração de linhagem de células de ovário de hamster chinês recombinantes de alta produção para produção de proteína terapêutica |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240043878A1 (https=) |
| EP (2) | EP4214308B1 (https=) |
| JP (1) | JP2023544267A (https=) |
| KR (1) | KR20230068401A (https=) |
| CN (1) | CN116457468A (https=) |
| AU (1) | AU2021342718A1 (https=) |
| BR (1) | BR112023005002A2 (https=) |
| CA (1) | CA3195524A1 (https=) |
| ES (1) | ES3010648T3 (https=) |
| HU (1) | HUE070250T2 (https=) |
| IL (1) | IL301442A (https=) |
| MX (1) | MX2023003278A (https=) |
| PL (1) | PL4214308T3 (https=) |
| TW (1) | TWI912369B (https=) |
| WO (1) | WO2022058603A1 (https=) |
| ZA (1) | ZA202303597B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12529071B2 (en) | 2019-03-19 | 2026-01-20 | Sanofi | Selection marker-comprising cell line and uses thereof for protein production |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| KR100267720B1 (ko) | 1997-12-29 | 2001-03-02 | 박호군 | 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법 |
| US20030166201A1 (en) * | 2001-04-30 | 2003-09-04 | Jensen Michael C. | Selection systems for genetically modified cells |
| JP5756016B2 (ja) * | 2008-10-29 | 2015-07-29 | サンガモ バイオサイエンシーズ， インコーポレイテッド | グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物 |
| EP2674495A1 (en) * | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
| AU2015334872B2 (en) * | 2014-10-23 | 2021-12-16 | Sanofi | Novel selection marker for cell transfection and protein production |
| US12497624B2 (en) * | 2018-07-13 | 2025-12-16 | Lonza Ltd | Methods for improving production of biological products by reducing the level of endogenous protein |
| WO2020012446A1 (en) * | 2018-07-13 | 2020-01-16 | Enzene Biosciences Limited | Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom |
| US12529071B2 (en) * | 2019-03-19 | 2026-01-20 | Sanofi | Selection marker-comprising cell line and uses thereof for protein production |
| WO2020243642A2 (en) * | 2019-05-31 | 2020-12-03 | The Trustees Of Columbia University In The City Of New York | Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof |
| CN110343668B (zh) * | 2019-07-23 | 2021-11-19 | 珠海联邦制药股份有限公司 | 一种敲除gs基因的cho细胞株及其制备方法与应用 |
-
2021
- 2021-09-17 TW TW110134938A patent/TWI912369B/zh active
- 2021-09-21 PL PL21777795.2T patent/PL4214308T3/pl unknown
- 2021-09-21 ES ES21777795T patent/ES3010648T3/es active Active
- 2021-09-21 AU AU2021342718A patent/AU2021342718A1/en active Pending
- 2021-09-21 WO PCT/EP2021/075864 patent/WO2022058603A1/en not_active Ceased
- 2021-09-21 CA CA3195524A patent/CA3195524A1/en active Pending
- 2021-09-21 EP EP21777795.2A patent/EP4214308B1/en active Active
- 2021-09-21 MX MX2023003278A patent/MX2023003278A/es unknown
- 2021-09-21 IL IL301442A patent/IL301442A/en unknown
- 2021-09-21 BR BR112023005002A patent/BR112023005002A2/pt unknown
- 2021-09-21 US US18/245,872 patent/US20240043878A1/en active Pending
- 2021-09-21 HU HUE21777795A patent/HUE070250T2/hu unknown
- 2021-09-21 KR KR1020237009323A patent/KR20230068401A/ko active Pending
- 2021-09-21 CN CN202180074963.4A patent/CN116457468A/zh active Pending
- 2021-09-21 EP EP24214023.4A patent/EP4541812A3/en active Pending
- 2021-09-21 JP JP2023518094A patent/JP2023544267A/ja active Pending
-
2023
- 2023-03-15 ZA ZA2023/03597A patent/ZA202303597B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL301442A (en) | 2023-05-01 |
| MX2023003278A (es) | 2023-04-12 |
| EP4214308B1 (en) | 2024-11-20 |
| US20240043878A1 (en) | 2024-02-08 |
| AU2021342718A9 (en) | 2025-03-27 |
| CN116457468A (zh) | 2023-07-18 |
| KR20230068401A (ko) | 2023-05-17 |
| EP4214308A1 (en) | 2023-07-26 |
| HUE070250T2 (hu) | 2025-05-28 |
| PL4214308T3 (pl) | 2025-04-14 |
| TWI912369B (zh) | 2026-01-21 |
| ZA202303597B (en) | 2024-08-28 |
| ES3010648T3 (en) | 2025-04-04 |
| WO2022058603A1 (en) | 2022-03-24 |
| AU2021342718A1 (en) | 2023-06-08 |
| TW202227622A (zh) | 2022-07-16 |
| JP2023544267A (ja) | 2023-10-23 |
| EP4541812A2 (en) | 2025-04-23 |
| CA3195524A1 (en) | 2022-03-24 |
| EP4541812A3 (en) | 2025-06-11 |
| EP4214308C0 (en) | 2024-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018070250A2 (pt) | linhagem celular para proteína recombinante e/ou produção de vetores virais | |
| BR112022027096A2 (pt) | Composições e métodos relacionados a agentes terapêuticos ativáveis | |
| Chung et al. | Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation | |
| Zhang et al. | Identification of novel dipeptidyl peptidase 9 substrates by two‐dimensional differential in‐gel electrophoresis | |
| BR112017008165B8 (pt) | anticorpo de domínio único direcionado contra um componente intracelular e seu uso, métodos in vitro para medir os níveis do referido anticorpo e para diagnosticar um distúrbio mediado por um componente intracelular, polipeptídeo isolado e composição compreendendo o referido anticorpo ou polipeptídeo isolado | |
| BR112023005002A2 (pt) | Geração de linhagem de células de ovário de hamster chinês recombinantes de alta produção para produção de proteína terapêutica | |
| BR0114373A (pt) | Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante | |
| BR112019023329A2 (pt) | Composição, grânulo, aditivo de ração animal, ração animal, formulação líquida, métodos para aprimorar um ou mais parâmetros de desempenho de um animal, para preparar uma ração animal e para produzir o polipeptídeo, uso da composição, polipeptídeo isolado, polinucleotídeo, construto ou vetor de expressão de ácido nucleico, e, célula hospedeira recombinante | |
| BR112018006995A2 (pt) | receptores anti-cd30 de antígeno quimérico | |
| BR112016014810A2 (pt) | Antagonistas de fcrn e métodos de uso | |
| BR112015018416A2 (pt) | fórmulas à base de proteína hidrolisada e aminoácidos com um sistema de emulsão estável | |
| BR112021012240A2 (pt) | Terapia de gene-célula-tronco hematopoiética para síndrome wiskott-aldrich | |
| BR112018071107A2 (pt) | composições e métodos para a detecção de proteínas da célula hospedeira | |
| BR112021026789A2 (pt) | Sialidases humanas recombinantes, proteínas de fusão de sialidase e métodos de uso das mesmas | |
| BR112017012484A2 (pt) | vírus isolado, cultura celular, gene que codifica uma proteína, proteína, fragmento de dna, vírus de vetor recombinante vivo, pseudo-partícula, vacina, anticorpo ou antissoro, método para a preparação de uma vacina, e, kit de teste diagnóstico. | |
| Sase et al. | Hypoxia-induced production of peptidylarginine deiminases and citrullinated proteins in malignant glioma cells | |
| BR112023003468A2 (pt) | Variantes de uma xiloglucanase da família 44 | |
| BR112022004497A2 (pt) | Administração intranasal de escetamina | |
| BR112022006923A2 (pt) | Polipeptídeos recombinantes para localização celular regulável | |
| Nakasato et al. | A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15 | |
| BR112015025898A2 (pt) | polipeptídeo, célula, ácido nucleico, vetor, vírus da varíola suína recombinante, composição, vacina, e uso de um peptídeo sinal | |
| BR112016014072A2 (pt) | anticorpo isolado, sintético ou recombinante humano, ou uma parte funcional ou um equivalente funcional do mesmo, molécula de ácido nucleico isolado, sintético ou recombinante, vetor, célula isolada ou recombinante ou um animal não humano, composição, uso de um anticorpo ou parte funcional ou equivalente funcional, e, métodos para produzir um anticorpo ou parte funcional ou equivalente funcional, para detectar células mieloproliferativas ou linfoproliferativas, para determinar se uma célula mieloide ou célula linfoide é uma célula mieloproliferativa ou célula linfoproliferativa, para identificar células mieloproliferativas ou linfoproliferativas, para determinar se células mieloproliferativas ou linfoproliferativas estão presentes em uma amostra, para tratar e/ou prevenir um distúrbio mieloproliferativo ou linfoproliferativo, para determinar se um indivíduo sofre de um distúrbio mieloproliferativo ou linfoproliferativo, para tipificar uma amostra contendo célula mieloide ou uma amostra contendo célula linfoide de um indivíduo, e, para determinar se um paciente que sofre de um distúrbio mieloproliferativo ou distúrbio linfoproliferativo é um candidato para o tratamento com um anticorpo | |
| MX388883B (es) | Mutaciones en proteinas del grupo hierro-azufre que mejoran la utilizacion de xilosa. | |
| BR112021010338A2 (pt) | Células hospedeiras fúngicas filamentosas modificadas | |
| Guo et al. | Ubiquitin specific peptidase 4 stabilizes interferon regulatory factor protein and promotes its function to facilitate interleukin-4 expression in T helper type 2 cells |